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Abstract
Objective: To understand factors affecting the compliance of malnourished,
HIV-positive adults with a nutritional protocol using ready-to-use therapeutic
food (RUTF; Plumpy’nut
 R ).
Design: Qualitative study using key informant interviews, focus group discussions
and direct observations.
Setting: Ministry of Health HIV/programme supported by Me ´decins Sans Frontie `rs
(MSF) in Nyanza Province, Kenya.
Subjects: Adult patients (n 46) currently or previously affected by HIV-associated
wasting and receiving anti-retroviral therapy, their caregivers (n 2) and MoH/MSF
medical employees (n 8).
Results: Thirty-four out of forty-six patients were receiving RUTF (8360kJ/d) at the
time of the study and nineteen of them were wasted (BMI,17kg/m
2). Six of
the thirteen wasted out-patients came to the clinic without a caregiver and were
unable to carry their monthly provision (12kg) of RUTF home because of physical
frailty. Despite the patients’ enthusiasm about their weight gain and rapid
resumption of labour activities, the taste of the product, diet monotony and
clinical conditions associated with HIV made it impossible for half of them to
consume the daily prescription. Sharing the RUTF with other household members
and mixing with other foods were common. Staff training did not include ther-
apeutic dietetic counselling.
Conclusions: The level of reported compliance with the prescribed dose of RUTF
was low. An improved approach to treating malnourished HIV-positive adults in
limited resource contexts is needed and must consider strategies to support
patients without a caregiver, development of therapeutic foods more suited to
adult taste, speciﬁc dietetic training for health staff and the provision of liquid
therapeutic foods for severely ill patients.
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Undernutrition associated with HIV is a public health
concern in Africa. Demographic and health surveys in eleven
sub-Saharan countries estimated that 10?3%ofHIV-infected
women (aged 15–49 years) had a BMI,18?5kg/m
2(1);d a t a
for men were not available. In urban Lusaka, Zambia, 9% of
adults (3624 out of 40778) started anti-retroviral therapy
(ART) with a BMI,16?0kg/m
2(2).
Despite the increasing availability of ART, and
patients enrolled in food programmes while on treatment
reporting greater adherence to their medication
(3,4),
HIV wasting is still common. Although the beneﬁcial
effects of ART on severe malnutrition in adults are well
documented, Carr
(5) reported severe toxicity associated
with ART in well-nourished individuals, and it has been
suggested that side effects may be worse in malnourished
individuals
(6).
However, the relationship between nutritional status,
therapy and survival of adults undergoing ART is con-
troversial. According to Paton et al.
(7), a BMI,17kg/m
2
at the time of starting ART is associated with decreased
survival in adults. A large observational study of patients
receiving ART in Kenya and Cambodia (n 5069) showed
that a weight gain of only 5% in 3 months increased
survival in adults with a BMI,17kg/m
2(8).
Bahwere et al.
(9) reported that a novel ready-to-use
therapeutic food (RUTF), nutritionally similar to commercially
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*Corresponding author: Email ﬁlippo@validinternational.org r The Authors 2011available paediatric RUTF, was acceptable to malnourished
Malawian patients who were not receiving ART, and that it
improved their physical activity performance, nutritional
status and survival.
On the other hand, Ndekha et al.
(10) found no differ-
ence in short-term survival when providing an energy-
dense RUTF, or a lower-density porridge-based food,
despite an increased weight gain with RUTF (n 450).
A retrospective analysis
(11) of surveillance data on
adults under ART (n 329) and with a BMI,17kg/m
2,
who were either receiving or not receiving an RUTF
(Afya; Compact AS, Bergen, Norway), also reported that it
was difﬁcult to conclude a clear beneﬁt of supplementary
food in the early months of ART in terms of survival.
In 2007, the UN ofﬁcially approved the use of RUTF for
the treatment of acute malnutrition in children
(12).T h i s
approach has also been adopted in nutrition and health
programmes in developing countries targeting adults
with HIV/AIDS. However, only a paediatric formulation is
commercially available and there is limited evidence for its
efﬁcacy, and little data on acceptability and adherence to
this formulation in HIV/tuberculosis (TB)-positive adults.
To understand why nutritional support may not be
providing consistent beneﬁts, it is necessary to investi-
gate, among other things, the compliance of patients to
nutritional treatment and understand the factors that
affect this. In the present paper, we use ‘compliance’
to describe the extent to which a person’s behaviour –
taking medication, following a diet and/or executing
lifestyle changes – corresponds to agreed recommenda-
tions from a health-care provider
(13–15).
The research questions of the present study aim (i) to
understand and describe compliance with a protocol based
on a speciﬁc RUTF (Plumpy’nut
 R ; Nutriset, Malaunay,
France) among malnourished adults living with HIV; and
(ii) to determine any key barriers to compliance.
To our knowledge, the present study is the ﬁrst
to qualitatively investigate compliance with nutritional
protocols based on RUTF that aim at rehabilitating mal-
nourished HIV adults. We report the results according to
the COREQ (consolidated criteria for reporting qualitative
research) guidelines
(16).
Experimental methods
The present research took place in Homa Bay, Nyanza
Province, which is on the Kenyan side of Lake Victoria. In
Kenya, in 2007, the prevalence of HIV was the highest
in Nyanza Province (15?3%), more than double the
national prevalence estimate
(17). In January 2006, the
non-governmental organisation Me ´decins Sans Frontie `res
(MSF), France, introduced a nutritional rehabilitation
programme for malnourished adults enrolled in the
Ministry of Health (MoH) ART programme, Kenya, which
utilised the most commonly available RUTF (brand
name: Plumpy’nut
 R ; 8360kJ/d (2000kcal/d) equal to four
sachets of 92g each). Adults ($15 years of age) were
considered malnourished (admission criteria) when BMI
was ,17kg/m
2 and/or middle upper-arm circumference
(MUAC) was ,185mm and/or the presence of oedema
was observed. Discharge criteria from the nutrition pro-
gramme included BMI$18kg/m
2 and MUAC$185mm,
and absence of oedema in at least two consecutive visits.
Along with the supply of RUTF, the medical staff provided
generic nutritional counselling. These same staff members
had never received any speciﬁc training in therapeutic
nutritional treatment counselling for HIV adult patients.
Subjects recruitment and sampling
The study subjects, enrolled at the MoH/MSF HIV/TB
programme in Homa Bay health district, Nyanza Province,
Kenya, came from three groups: patients enrolled in the
p r o g r a m m e( s o m ea l r e a d yn u t r i t i o n a l l yr e h a b i l i t a t e d ) ;
their caregivers; and medical staff (counsellors, nurses and
clinical ofﬁcers). Patients ,15 years of age were not
admitted into the study group. The patients were recruited
either at MoH/MSF HIV clinics A and B at Homa Bay
hospital or from TB wards 7 and 8 of the same hospital.
The study followed a non-probabilistic, purposive,
heterogeneous, non-proportional quota sampling system.
Data saturation was achieved after approximately two-
thirds of the study; however, recruitment continued along
the entire planned period (3 weeks). During the study
period, patients coming for their usual routine visit were
invited to participate by the nurse in charge of the nutrition
programme. All the health staff working at the clinic during
the study agreed to participate. All focus group discussions
and interviews occurred in a quiet area within the HIV
clinic compound in the presence of researchers only,
whereas direct observations were made in the TB multi-
drug resistance ward at Homa Bay hospital.
Data collection and data analysis
The research applied three qualitative methods and the
results were triangulated. Focus group discussions involved
patients and caregivers and one separate session with
members of the MoH/MSF medical staff; semi-structured
interviews were administered to patients on a one-to-
one basis; direct unobtrusive observations were made of
Plumpy’nut
 R distribution and consumption in the HIV/TB
wards. The questionnaires and focus group discussions used
a variety of techniques, including free listing, ranking exer-
cises and open-ended questions (see footnotes in Table 3).
Questionnaires and focus group guides
Two guides were developed and piloted for use in the focus
groups: one for patients and caregivers and one for the
health staff members. The guides and questionnaires cov-
ered four topics: (i) information provided to patients about
the recommended use and consumption of Plumpy’nut
 R ;
(ii) knowledge and attitude of patients about the role of
S
P
u
b
l
i
c
H
e
a
l
t
h
N
u
t
r
i
t
i
o
n
2 F Dibari et al.Plumpy’nut
 R in their therapy; (iii) dietary practices and
Plumpy’nut
 R consumption; and (iv) patient’s and caregiver’s
experience of the Plumpy’nut
 R distribution system.
A checklist for the direct observations was developed
and covered the ways of consuming Plumpy’nut
 R , their
advantages and disadvantages, together with the role of
the caregiver.
All focus group discussions were recorded on tape,
allowing the checking of information that was not clear
from the written notes. The focus group discussions
and interviews did not last for more than 1.5 and 1h,
respectively. The direct observation sessions lasted
between 30min and 1h. A small number of photographs
were taken with the informed consent of patients.
The research team and the relationship with subjects
The focus group discussions and interviews were con-
ducted in the Luo language. Two native speakers, a female
and a male, were recruited as interpreters and provided
with 2d training on the study and methods to be used.
Time for familiarisation with the study guides was provided.
The principal researcher was a Caucasian male who
was trained in public health nutrition at MSc level, and
was not an MSF employee. He attended all focus group
sessions and beneﬁted from simultaneous translation by
an interpreter. The principal researcher personally facili-
tated, in English, the focus group discussion with the
health staff, and subsequently transcribed the recorded
tape himself. Other discussions were facilitated by the
study interpreters. The discussion transcript was not
returned to the members for comments or corrections. All
participants were provided with information about the
study and assured that clinical services or RUTF provision
would not be affected by refusal to participate.
Identiﬁcation of common themes
The focus group discussion transcripts were manually
coded by the principal researcher, highlighting keywords,
key concepts and any minor or contradictory themes.
Records of direct observations were reviewed and evi-
dence summarised. Quantitative data from the interviews
and the clinical and socio-economic proﬁle of the focus
group participants were entered in EpiInfo version 3?4?3
(Centers for Disease Control and Prevention, Atlanta, GA,
USA) and analysed in the STATA statistical software pack-
age version 8?0 (Stata Corp., College Station, TX, USA).
Detailed tables were prepared for each identiﬁed theme
and its associated sub-themes. The theme tables contained
separate columns referring to the evidence obtained on
each theme using one of the three research methods. This
allowed triangulation of evidence and comparison and
discussion of the common themes that emerged. Following
this process, the themes and sub-themes from the separate
tables were compiled and overall conclusions drawn.
Conclusions and associated recommendations were
discussed with the health and management staff of the
programme during a feedback process.
Results
From January 2008 to March 2009, MSF admitted 782
malnourished adults into the therapeutic nutrition pro-
gramme; the monthly mean weight gain was 1?8( SD 0?5)
and 1?8( SD 0?6)g/kg per d, respectively, for severely and
moderately malnourished adults.
Study group characteristics
Table 1 provides descriptive data on the forty-six parti-
cipating patients. Thirty-four were still under treatment
with Plumpy’nut
 R . More than half of them were women
and the average age was 33 years. All patients were
married and the majority had their spouse still alive;
twelve out of the forty-six patients were widowers. All
subjects who were approached agreed to participate in
the study and provided written informed consent.
Table 2 summarises the methods used and the number
of patients, caregivers and health staff participants.
Twenty-two current and ex-patients received one-to-one
interviews and eighteen participated in focus group
discussions. Six in-patients were directly observed. Two
caregivers were recruited to participate in focus group
discussions. Eight MoH/MSF employees participated in
the focus groups with the medical staff (counsellors,
nurses and medical doctors). None of the subjects were
involved in more than one data collection method.
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Table 1 Proﬁle of participating patients (n 46)
Participants
Characteristic n %
Male 18 39
Female 28 61
Age (years) 33?3
Married (missing records51) 45 100
Spouse alive 33 73
Widowers 12 27
Mean number of children (missing
records51)*
3?0
Serological status (missing records56)
HIV positive 24 60
HIV/TB positive 16 40
Nutritional rehabilitation (missing
records51)
Enrolled into the nutrition programme at
the time of the study
No longer meeting admission criteria
of malnutrition-
15 33
Meeting admission criteria of
malnutrition-
-
19 42
Discharged by the time of the study 11 25
TB, tuberculosis; MUAC, middle upper-arm circumference.
*Age not speciﬁed.
-BMI$17kg/m
2 and/or MUAC$185mm.
-
- This group included thirteen out-patients and six in-patients. The in-patients
were from the TB multi-drug resistance ward.
RUTF compliance during AIDS 3Among the out-patients (n 13) who were still mal-
nourished, six travelled to the clinic without a caregiver
on the day of the study (two missing data). One walked,
whereas the rest took public transport; the average time
to reach the clinic was almost 2h. The six in-patients
recruited for the direct observations were found in the
TB wards of Homa Bay hospital and they were all HIV
positive; two of them were multi-drug resistant and their
appetite might have been affected by their TB status
and/or HIV status, plus by side effects of speciﬁc drugs.
Understanding compliance
The following sections summarise the key themes emer-
ging from the analysis of the results. Only fourteen out of
twenty-two interviewed patients reported complying with
the prescribed amount of Plumpy’nut
 R .
Perceptions about Plumpy’nut
 R
Table 3 lists the aspects that may both enhance or
decrease compliance with Plumpy’nut
 R , and were
mentioned during the majority of focus groups and
interviews. It was frequently reported that Plumpy’nut
 R
can be ‘associated with a drug’ (same role and effect of a
drug), ‘brings (physical) strength’ and ‘allows to go back
to work’. Increases in weight gain were reported and
feelings of hunger said to decrease. Positive feelings
about the use of the product can be summarised by the
quote: ‘ART is a drug to ﬁght the infections, but does not
give strength like Plumpy’nut
 R to go back to work’.
Turning to the negative perceptions of participants,
some patients complained that the taste of Plumpy’nut
 R
was responsible for nausea and vomiting. Participants
also argued that the ‘ﬁrst 3 or 4d are the most critical ones’
and that ‘after then, it becomes easier’ to comply with the
prescription. Among the patients interviewed, only one
out of forty mentioned oral thrush as the main cause for
low acceptability. In contrast, the health staff focus group
voiced that the initial clinical conditions including swal-
lowing capacity are crucial for patients’ compliance. The
interviewees provided suggestions about how to improve
the product (see Table 3).
The medical staff expressed doubts about the role of
Plumpy’nut
 R in promoting weight gain, since ‘ART is far
more important in severely malnourished patients’.
Sharing practices
Compliance was found to be closely linked with food-
sharing practices. More than half (fourteen out of twenty-
two) of the interviewed patients reported sharing
Plumpy’nut
 R with children and other adults and this was
conﬁrmed by most focus groups. The medical staff was
particularly concerned about the sharing practice at the
community level, because of their observation that ‘yin the
hospital wards, it is common’. In two of the focus groups,
patients reported incidents of Plumpy’nut
 R trading or sell-
ing. This, however, seems to be limited to schoolchildren,
because among adults the product was associated with
HIV treatment and was thus potentially stigmatising. The
majority of patients who declared that they tried to prevent
sharing (‘hiding the product in the closet from children’;
‘yor from adults’) did so because Plumpy’nut
 R was con-
sidered part of the ‘medical drug prescription’. Only one
interviewee reported that Plumpy’nut
 R could be actually
harmful for an HIV-negative person. One member of the
medical staff suggested that Plumpy’nut
 R is so important for
household food security that sharing represents a strategy
to delay the moment of programme discharge.
Mixing Plumpy’nut
 R with other foods
Only one patient reported consuming Plumpy’nut
 R exclu-
sively, whereas mixing Plumpy’nut
 R with other food was
a common practice mainly with local staple starchy food
(ugali), fresh vegetables, ﬁsh, rice, cereals, legumes, meat,
cooked vegetables (sukuma wiki) and chapatti (in order of
reported frequencies). Monotony of diet, nausea, vomiting
or salty taste were the main reasons for mixing. Stirring
Plumpy’nut
 R into hot water produces something that is
similar to a popular, peanut-based, traditional food (ogila).
Some others mentioned that ‘once you start mixing the
Plumpy’nut
 R ,i ti sh a r dt og ob a c ka n de a ti ta l o n e ’ .M e m b e r s
of the medical staff suggested (contrary to programme
recommendations) that patients with severe clinical condi-
tions (e.g. oral thrush) should mix the Plumpy’nut
 R with tea.
Key barriers to compliance
Inability to transport ration
Physical weakness, absence of a caregiver during
collection of supplies, cost of transport and stigma were
key barriers to compliance. The prescribed supply of
Plumpy’nut
 R per out-patient was monthly and weighed
approximately 12kg. A malnourished out-patient without
a caregiver did not have enough strength to carry such
weight. Therefore, the out-patients were invited to take
half of the monthly ration and come back to collect the
second half of the supply in 2 weeks’ time. Health staff
members reported that most patients could not afford to
travel twice a month to the clinic. It can be speculated that
these patients spread out the 2 weeks’ provision along
the entire month. This is consistent with the reports of
many patients. No data could be collected on how many
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Table 2 Summary of methods and participants
Methods
Participants
(n 56)*
Individual interviews with current and ex-patients 22
Five focus group discussions from three to ﬁve
participants, including:
Current and ex-patients 18
Caregivers 2
Direct observations on individual in-patients and their
caregiver’s role
6
One focus group discussion with health staff 8
*None of the study subjects participated in more than one method.
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Table 3 Summary of key themes and sub-themes
Theme
Individual
interviews
Focus group
discussions*
Direct
observations
Compliance with Plumpy’nut
 R
> Only approximately half of the patients complied with the prescribed amount X- –X
Positive aspects reported about Plumpy’nut
 R – participants think that:
> It is similar to a drug rather than a food, in terms of both usage and role in recovery
> It ‘brings strength’
> It ‘allows to go back to work’
> Increases weight gain
> Decreases the feeling of hunger
> Has a smell and packaging that are well accepted
> Offers the possibility to mix it with other food and therefore reduce:
J diet boredom
J nausea
X--
- X–
X--
- X–
X--
- X–
X--
- X
X--
- X–
X--
- XX
X--
- XX
X- X-
- y –
X- X-
- y X
Negative aspects reported about Plumpy’nut
 R – participants think that:
> It can cause nausea and vomiting
> The ﬁrst 3–4d of consumption are crucial for compliance, becoming easier later
> The taste is:
J too sweet
J too oily
J too salty
> Consistency should be more liquid or like a biscuit or a powder (milk powder)
> It comprises a monotonous diet, leading to boredom
X--
- XX
–XX
X--
- X-
- y –
X--
- X-
- y –
X--
- X-
- y –
X--
- X–
X--
- X–
Sharing Plumpy’nut
 R with both other adults and/or children is a common practice X- X–
Reasons for sharing:
> Food insecurity in the household
> Children like it
> The partner or relative is ill and/or HIV positive but not malnourished (energy booster)
–X -
- –
X--
- X-
- –
–X -
- –
Mixing Plumpy’nut
 R with foods is a common practice X X X
Reasons for mixing:
> To reduce monotony of the diet
> To reduce nausea, vomit, salty taste
> Because the Plumpy’nut
 R has separated into oil and solid phases
> Because Plumpy’nut
 R with water reminds participants of a traditional food
> Because it was suggested by the health staff
X--
- X-
- X
X--
- X-
- X
X--
- ––
–X -
- –
–X -
- –
Knowledge and attitudes of medical staff
Medical staff expressed doubts about the positive role played by Plumpy’nut
 R in nutritional
rehabilitation; ART was perceived as being much more important
–X –
Patient counselling
> Counselling messages focus on:
J human nutrition (e.g. ‘proteins are available in meat, eggs and cheese’)
J improvement of general conditions when consuming Plumpy’nut
 R (weight gain, appetite,
strength)
> Most patients did not know the relationship that exists between HIV infection, their thinness
and their ART therapy
> Staff declared that they did not know what counselling to provide to patients with severe
clinical conditions (e.g. oral thrush)
> Most patients do not receive routine information about why, when and how to consume
Plumpy’nut
 R ; when this happens, it comes from the individual initiative of the health staff
X--
- X-
- y –
X--
- X-
- –
X--
- X-
- X
X--
- X-
- X
Distribution system for Plumpy’nut
 R
> Half of the patients still under nutritional rehabilitation come to the HIV clinic without a
caregiver
> The patients cannot carry more than a 2 weeks’ supply of Plumpy’nut
 R (,6kg) instead of the
whole month’s supply
> The appointment schedule for ART or clinical check-ups is monthly in most cases; therefore,
patients or caregivers do not come back to collect the missing 2 weeks’ supply of
Plumpy’nut
 R
> Very weak patients are in absolute need of the caregiver even to open the sachets, to mix it
with other food (when needed) and consume it
> Bulky supply (6–12kg) and branded container (box) are very noticeable and associated with
stigma within the community
X- X–
X- XX
X- X–
––X
X- XX
ART, anti-retroviral therapy.
*The focus groups involved either patients together with caregivers (ﬁve groups, with three to ﬁve participants) or health staff members (one group with eight
participants).
-Tool used: closed and/or open questions.
-
- Tool used: free listing.
yTool used: ranking exercise to select the main themes reported here.
RUTF compliance during AIDS 5patients came back to collect the missing mid-month
supply or the relationship with defaulting and survival.
Stigma associated with therapeutic foods
In a region where HIV-related secondary malnutrition is
common and treated with Plumpy’nut
 R , this product has
become strongly associated with HIV. For this reason
many patients were reluctant to walk home with boxes
reading the brand name (Plumpy’nut
 R ). One patient said
‘I can disguise the ART tablets saying that they cure
something else, but I cannot disguise Plumpy’nut
 R
because a month’s supply is too bulky and visible’.
Clinical status and role of the caregiver
Among the in-patients who were directly observed, all
patients with a severe clinical condition could not comply
with the prescribed amount. Two of them died during the
course of the study. Alternative therapeutic diets, such as
therapeutic liquid milk (formulas F75 and F100), the
intake of which may have been easier for severely ill
patients, was not available.
It was reported and observed that in-patients in the
ward with the most severe clinical conditions can consume
Plumpy’nut
 R only if mixed with other suitable food (e.g.
water or porridge). This requires assistance from the care-
giver. Patients with severe clinical conditions were so weak
that they did not have sufﬁcient strength even to open the
sachet and mix the product with food.
Discussion
The present study has indicated that compliance with
therapeutic feeding within this HIV programme is likely
to be low. We have identiﬁed a number of issues that may
reduce the consumption of RUTF to below the prescribed
level. Although the nature of the study setting might have
affected the patients’ response, some of the ﬁndings are
likely to be generalisable to other HIV and adult nutrition
programmes that use this speciﬁc therapeutic food and a
similar nutritional protocol.
The present study identiﬁed two groups of factors that
limit speciﬁcally an RUTF-based protocol compliance:
(i) factors directly related to the product design and
(ii) factors related to programme design.
Factors related to product design
Although widely used for other patient groups, it is
important to note that Plumpy’nut
 R was designed for
treating severe acute malnutrition in children. There is
evidence
(18) to suggest that reported symptoms such
as nausea and vomiting when consuming RUTF could
be related to the drug treatment too. The taste of
Plumpy’nut
 R was not considered suitable by many adult
patients and therefore they often reduced intake or mixed
it with other food. This practice may compromise the
efﬁcacy of RUTF by reducing overall energy and nutrient
intake and delaying nutritional rehabilitation.
Despite the problems of taste and consistency accept-
ability, the results of this research suggested that most
patients valued the nutritional therapy provided by
Plumpy’nut
 R . Their attitude towards the product was more
positive than that of most medical employees, perhaps
because of lack of staff training on the anticipated beneﬁts.
However, the interviewed patients would reduce the
sweetness (somebody suggested the addition of lemon
juice), and would like to change the consistency into
something ‘more liquid’ or ‘into the form of a biscuit’ or
powder. Rarer comments mentioned included suggestions
for improving the packaging, such as ‘the sachet packaging
should be replaced with ice-cream cup with lid’.
Factors related to programme design
Certain problems in accessing and consuming the ther-
apeutic food were accentuated by the design of the
overall programme and inappropriate staff training.
Patients were not informed about how to correctly con-
sume the RUTF. For example, counselling messages
inappropriately advised adding the RUTF to tea and
advised feeding strategies that were not feasible for
the patient. Advice to consume RUTF at meal times
(3 times/d) and/or together with ART drugs was not
conducive to ensuring adequate intake. Some of the
patients admitted that they disregarded such advice
because of the ‘strong’ – difﬁcult to eat – nature of the
product, their bad clinical conditions combined with ART
side effects (lack of appetite, nausea, vomiting, etc.).
More appropriate advice would have been that based
on therapeutic feeding guidelines
(19) and should have
recommended having small bites of RUTF throughout the
day until the daily prescription of sachets was consumed.
Box 1 presents the most common questions expressed by
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Box 1
During dietetic counselling* sessions, the topics to
be covered should respond to the following ques-
tions expressed by patients during the study: What
is Plumpy’nut
 R (food/drug; composition)? Who is
supposed to use it? What are its components? How
often should I eat it along the day? What should I do
when I do not manage to eat it because of nausea,
vomiting or lack of appetite? Could I mix it with
other foods? What should I avoid to drink or eat
together with Plumpy’nut
 R ? What are the conse-
quences if I share my ration of Plumpy’nut
 R with
other persons? Is it good for somebody who is not
HIV positive to eat Plumpy’nut
 R ? Is it good for
somebody who is not thin to eat Plumpy’nut
 R ?
When should I stop eating Plumpy’nut
 R ? Will I
become thin again when I stop eating it?
*For an example of dietetic counselling material for HIV ther-
apeutic feeding in adults, contact ﬁlippo@validinternational.org.
6 F Dibari et al.patients during the present study. The same questions
lead to key counselling messages.
Frail patients who came to a clinic appointment with-
out a caregiver sometimes ended up losing half of the
prescribed RUTF supply, as they were unable to transport
the food to their home. The situation could be improved
by re-design of the distribution system, perhaps involving
community-based organisations to support home-based
care. Their importance is recognised in many HIV and
nutrition interventions and protocols
(20–24). The health
programme also needed to acknowledge and address
the stigma factor attached to Plumpy’nut
 R . This could
involve the use of anonymous packaging.
In case of extremely frail patients, the caregiver played
a fundamental role in trying to overcome key barriers
for compliance, such as simply opening the sachets or
mixing it with other foods.
Main limitations of the present study
The present research did not correlate the collected data
with clinical information such as patients’ survival, CD4
count, weight gain or BMI changes that might have
helped in understanding the impact of such a programme
in the presence of household/community sharing, food
mixing, lack of counselling and clinical difﬁculties in
swallowing among others.
The present research did not aim to understand the link
between nutritional therapy and ART compliance. RUTF
is meant to be used in out-patient programmes, but the
present study was restrained by lack of observations at
the community level.
The two study interpreters were not only employed as
health promoters in the MoH HIV programme but were
also clients of the MoH/MSF HIV/TB programme. One of
them had been previously successfully rehabilitated in the
nutritional programme. Therefore, they might have pre-
viously met some of the patients enrolled in the study
and/or developed speciﬁc perceptions about the topic,
introducing possible bias.
Conclusions
Overall, the research suggests that training and information
material is needed to ensure that medical staff can support
the patient to overcome the ﬁrst most crucial phase of
the treatment. The very ﬁrst contact with the patient should
include a test to assess the swallowing capacity. Reduced
capacity to swallow is common and it may imply a
lower compliance with nutritional therapy and an increase
in mortality risk. Consistent with the community-based
management of malnutrition approach, medical staff
should ask the patient to consume some amount of RUTF
in his presence to verify his swallowing capacity. Accord-
ing to the results of this test, dietetic solutions must be
discussed and agreed upon together with the patient and
the caregiver when present. Patients who are unable to
swallow at all should be hospitalised and treated according
to the in-patient nutritional therapeutic protocol developed
by WHO
(25), which utilises milk-based liquid therapeutic
nutritional products such as F75 and F100.
The study showed that Plumpy’nut
 R , designed for
malnourished children, needs improvement to meet the
palatability preferences expressed by adult patients.
A reduction in the perception of sweetness and fat com-
ponents was solicited by the patients. However, any
HIV/TB therapeutic nutrition programme should not
introduce newly designed RUTF until positive clinical
results have been demonstrated.
Further studies more closely correlating compliance
and recovery rates are likely to improve the perception
of medical staff towards the effectiveness of this kind of
programme, possibly improving their performance as well.
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